DUBLIN–(BUSINESS WIRE)–The “UAE Cancer Diagnostics Market, By Product (Consumable v/s Instruments), By Technology, By Application, By End User, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to ResearchAndMarkets.com’s offering.
The UAE cancer diagnostics market is expected to grow at a steady rate in the forecast period. The market growth can be attributed to the rising incidences and prevalence of various types of cancer and the advancing healthcare infrastructure in the country.
Technological advancements for better imaging of cancerous cells and an increase in government initiatives and other private organizations to spread awareness regarding early diagnosis & prevention of cancer are anticipated to boost the growth of the UAE cancer diagnostics market in the coming years.
Additionally, the growing number of diagnostic laboratories in the country and rising emphasis on health & safety regulations are driving the market growth. Collaborative and independent initiatives taken by the government and private organizations to create cancer awareness are contributing to increased health consciousness, which is aiding the growth of the UAE cancer diagnostics market.
The introduction of innovative products along with the rising need for early diagnosis is contributing to the rapid growth of the cancer diagnostics market during the forecast period. Moreover, cancer research organizations, both public and private entities, are investing heavily in research projects to launch advanced diagnostic tools in the market, which is supporting the market growth. Surging demand for early diagnosis of cancer, regular checkups, and routine tests to identify symptoms and find early treatments are anticipated to boost the UAE cancer diagnostics market.
Objective of the Study:
- To analyze the historical growth in the market size of UAE cancer diagnostics market from 2017 to 2021.
- To estimate and forecast the market size of UAE cancer diagnostics market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast UAE cancer diagnostics market based on product, technology, application, end user, region, and company.
- To identify dominant region or segment in the UAE cancer diagnostics market.
- To identify drivers and challenges for UAE cancer diagnostics market.
- To examine competitive developments such as expansions, new services, mergers & acquisitions, etc., in UAE cancer diagnostics market.
- To conduct pricing analysis in the UAE cancer diagnostics market.
- To identify and analyze the profile of leading players operating in UAE cancer diagnostics market.
-
To identify key sustainable strategies adopted by market players in UAE cancer diagnostics market.
Report Scope:
In this report, UAE cancer diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
UAE Cancer Diagnostics Market, By Product:
- Consumable
- Antibodies
- Kits & Reagents
- Probes
- Others
- Instruments
- Pathology Instruments
- Imaging Instruments
- Biopsy Instruments
UAE Cancer Diagnostics Market, By Technology:
- IVD Testing
- Imaging
- Biopsy
UAE Cancer Diagnostics Market, By Application:
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Others
UAE Cancer Diagnostics Market, By End User:
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
UAE Cancer Diagnostics Market, By Region:
- Abu Dhabi
- Sharjah
- Dubai
- Rest of UAE
Key Topics Covered:
1. Service Overview
2. Research Methodology
3. Executive Summary
4. Voice of Customer
5. Impact of COVID-19 on UAE Cancer Diagnostics Market
6. UAE Cancer Diagnostics Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Consumable v/s Instruments)
6.2.2. By Technology (IVD Testing, Imaging, Biopsy)
6.2.3. By Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Others)
6.2.4. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.5. By Company (2021)
6.2.6. By Region
6.3. Market Map
7. UAE Cancer Diagnostics Consumables Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Antibodies, Kits & Reagents, Probes, Others)
7.2.2. By Application
7.2.3. By End User
8. UAE Cancer Diagnostics Instruments Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Pathology Instruments, Imaging Instruments, Biopsy Instruments)
8.2.2. By Application
8.2.3. By End User
9. Market Dynamics
9.1. Drivers
9.2. Challenges
10. Market Trends & Developments
11. Competitive Landscape
12. Strategic Recommendations
Companies Mentioned
- GE Healthcare FZE
- Abbott Laboratories S A
- Roche Diagnostics Middle East FZCO
- FUJIFILM Middle East FZE
- Danaher Middle East LLC
- Agilent Technologies UAE
- Hologic Inc. UAE
For more information about this report visit https://www.researchandmarkets.com/r/x9ag8
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
